NCT06514534 2026-04-21
ASC4TARGET
Novartis
Phase 2 Recruiting
Clinical Trials
8 trialsNCT05943522 2026-04-20
Asciminib RMP Study
Novartis
Recruiting
NCT06308588 2026-04-14
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06368414 2026-04-02
AsterA
Korean Society of Hematology
Phase 2 Recruiting
NCT05143840 2026-03-23
ALERTCML
Augusta University
Phase 2 Recruiting
NCT04877522 2026-03-06
Asciminib Roll-over Study
Novartis
Phase 4 Recruiting
NCT06236724 2026-03-04
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06629584 2026-02-17
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting